Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update
-
Runway Growth Finance Corp. Reports Third Quarter 2024 Financial Results
-
Urgently Announces Third Quarter 2024 Financial Results
-
GEN Restaurant Group, Inc. Announces Third Quarter 2024 Financial Results
-
PubMatic Announces Third Quarter 2024 Financial Results
-
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
-
Lifecore Biomedical to Present at Stephens Annual Investment Conference
-
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
-
VirTra Reports Third Quarter and Nine Month 2024 Financial Results
-
FibroGen Reports Third Quarter 2024 Financial Results
-
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
Hallador Energy Company Reports Third Quarter 2024 Financial and Operating Results
-
SoundThinking Reports Third Quarter 2024 Financial Results
-
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
-
Oportun Completes Sale of its Credit Card Portfolio
-
EverCommerce Announces Josh McCarter as the Leader of Its EverPro Vertical
-
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
-
Inseego Reports Third Quarter 2024 Financial Results
-
MARA Announces Third Quarter 2024 Results
-
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
-
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
-
Commercial Vehicle Group Announces Departure of Carlos Jimenez
-
Oportun Reports Third Quarter 2024 Financial Results
-
Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates
-
EverCommerce Announces Third Quarter 2024 Financial Results
-
TMC Announces June 27, 2025 Submission Date for Subsidiary NORI’s ISA Application, and Expanded Company Strategy
-
Better Choice Company Inc. Announces Positive Third Quarter 2024 Results
-
Ceribell Reports Third Quarter 2024 Financial Results
-
ProPhase Labs Announces Closing of Public Offering of Common Stock
-
Paltalk, Inc. Reports Results for Third Quarter 2024
-
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
-
Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Silvaco Reports Third Quarter 2024 Financial Results
-
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Synchronoss Technologies Reports Third Quarter 2024 Results
-
Ormat Technologies Announces Major EPC Contract With Contact Energy for 101MW Geothermal Plant in New Zealand
-
Rumble Reports Third Quarter 2024 Results
-
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates
-
Iridex Reports Third Quarter 2024 Financial Results
-
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
-
PLBY Group Reports Third Quarter 2024 Financial Results
-
TeraWulf Reports Third Quarter 2024 Financial Results
-
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
-
Interparfums, Inc. Announces Initial 2025 Guidance
-
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
-
HF Foods Reports Third Quarter 2024 Financial Results
-
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
-
iBio Reports Fiscal First Quarter 2025 Financial Results
-
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

